Omyanutra® 300 from Omya

Omyanutra® 300 is a range of highly compactable porous mineral excipients that have been specifically developed for nutraceuticals. Omya is a global leader in the production of industrial minerals, and these new generation excipients help to overcome and facilitate the various challenges that formulators face when developing nutraceutical tablets. This unique range has a mechanical binding and higher mechanical stability and gives formulators the ability to form hard tablets at a low compression force.

Continue reading

Making Pharmaceuticals UK 2023

In April, Chemlink Specialties joined Harke Pharma at Making Pharmaceuticals UK 2023, the leading UK pharmaceutical exhibition & conference. This year the event was held in Coventry and provided an excellent platform to bring together a wide range of exhibitors and delegates from across the pharmaceutical industry to discuss, showcase and learn about all things pharma. 

Continue reading

Introducing Our New Pharma Principal: Omya

We’re pleased to welcome Omya to HARKE GROUP’s Life Sciences Division as one of our exciting new principals. Chemlink Specialities will offer the range of natural and functionalized Calcium Carbonates in the UK and Ireland. In this blog post, we’ll introduce you to the company and its current pharmaceutical and nutraceutical range and explain how you can request samples!

Continue reading

Plastic Packaging Tax

A £200 per tonne plastic tax will come into effect from the 1st April 2022 in the UK, what does it mean for our industry and how can we minimise the impact of this tax?Continue reading

Oral-Dispersible-Tablet Formulation Challenges

On Weds 27th May, Shilpa Mistry, our head of Pharma for UK and Ireland, delivered a webinar for Making Pharma on the challenges of formulating oral-dispersible-tablets (ODTs). In this blog we provide an overview of her presentation and the featured products for anyone who missed out on the webinar or who is looking for further details.

Continue reading